BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.29K Sell
190
-1,262
-87% -$58.4K ﹤0.01% 1075
2026
Q2
$62K Sell
1,452
-403
-22% -$21.9K 0.01% 883
2026
Q1
$116K Buy
1,855
+446
+32% +$35.7K 0.02% 704
2025
Q4
$134K Buy
1,409
+246
+21% +$24.1K 0.02% 678
2025
Q3
$114K Sell
1,163
-175
-13% -$18.1K 0.02% 673
2025
Q2
$144K Buy
1,338
+102
+8% +$10.3K 0.02% 559
2025
Q1
$125K Sell
1,236
-95
-7% -$9.6K 0.02% 620
2024
Q4
$119K Buy
1,331
+59
+5% +$5.19K 0.02% 596
2024
Q3
$107K Buy
+1,272
New +$100K 0.02% 694

Other funds holding BSX

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s BSX Position: Q3 2026 in Review

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. reduced its Boston Scientific (BSX) stake by 87% in Q3 2026, selling an estimated $58.4K and leaving 190 shares worth $8.29K. The position accounts for ﹤0.01% of the portfolio, ranked #1075.

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. first reported a position in BSX in Q3 2024 and has held it in 9 quarters since. The position peaked at $144K in Q2 2025. 1,192 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. held 190 shares of Boston Scientific worth $8.29K as of Q3 2026.
  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. sold 1,262 Boston Scientific shares in Q3 2026, an estimated $58.4K.
  • Boston Scientific made up ﹤0.01% of BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s portfolio in Q3 2026, its #1075 holding.
  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. first reported a position in Boston Scientific in Q3 2024 and has held it in 9 quarters since.
  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s Boston Scientific position peaked at $144K in Q2 2025.
  • 1,192 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s 13F filing for Q3 2026, filed 13 Nov 2026.